what are the differences between tirzepatide and semaglutide vs Tirzepatide vs. Semaglutide: Which is

The TRANSCEND-T2D-1 trial (NCT06354660) demonstrated HbA1c reductions of 1.7-2.0% and 36.6 lbs mean weight loss in type 2 diabetes participants over 40 weeks

Sustained weight loss with continued metabolic improvements. Lower risk of developing type 2 diabetes and cardiovascular disease. Improved energy levels and overall well-being

Pennsylvania was among 16 states that covered GLP-1s for obesity treatment last year, according to KFFs Medicaid budget survey in October

I took Ozempic, then got pancreatitis Read more here on the personal story of someone who took Ozempic and ended up experiencing pancreatitis as a side effect